News

  • Vermont bans herbicide over potential Parkinson’s link

    Vermont has become the first US state to ban paraquat, amid concerns over studies linking the herbicide to Parkinson’s disease. Phil Scott, the governor, signed the legislation on Tuesday. The new law takes effect on November 1, although it allows state regulators to issue special permits for paraquat use on fruit-producing tree orchards, berries and [...]

  • New award to celebrate kindness in brain injury care

    This year's NR Times Awards sees the introduction of a new category celebrating kindness in brain injury care. The Kindness in Brain Injury Care Award will recognise an individual or team who has brought not only skill and expertise to their role, but a profound sense of compassion and humanity. The recipient will have gone [...]

  • Hospital to pilot test that ‘will save lives’

    A rapid stroke test that can show whether a common drug will work is being piloted at a new Nottingham clinic. The cheek swab test is being offered at Queen’s Medical Centre, where a new clinic is assessing and treating patients after suspected minor stroke. It can show within hours whether a patient carries a [...]

  • ‘Irreversible’ spinal cord damage may be reversed, research suggests

    Spinal cord damage once thought irreversible may be reversible, after researchers grew miniature brain and spinal circuits in the lab. The early-stage research suggests nerve fibres connecting the brain and spinal cord may be able to regrow after damage if key biological signals are targeted. The findings could help scientists understand why paralysis and other [...]

  • ‘Voice of the Patient’ report captures lived reality of MS

    A new report has highlighted urgent gaps in MS diagnosis, symptom relief and treatment of disease progression. The Voice of the Patient report draws on nearly 3,000 survey responses and direct testimony from people affected by multiple sclerosis. Multiple sclerosis, or MS, is a long-term condition affecting the brain and spinal cord. It can cause [...]

  • Robotic pianist paves way to new Parkinson’s therapies

    US researchers have developed a robotic hand that can hear a melody once and play it back after just two minutes of self-taught practice on a keyboard, without relying on sheet music or pre-programmed scores. The scientists say that the approach could pave the way for new Parkinson’s therapies. The hand grew so capable that [...]

  • Italy probes Biogen over alleged attempt to block cheaper Sandoz MS drug

    Italy’s competition watchdog has opened a probe into Biogen over claims it tried to block access to a cheaper MS drug. The investigation concerns Biogen Italia and its US parent, Biogen, over allegations it tried to prevent rival drugmaker Sandoz from offering a cheaper multiple sclerosis treatment. Italy’s antitrust authority, AGCM, said on Wednesday, May [...]

  • CPotential extends partnership with Slater and Gordon

    A charity which supports young people with movement disorders is able to continue to develop its life-changing service through the extension of a partnership with a national law firm. For over 60 years, CPotential has worked with babies, children and teenagers who live with conditions including Cerebral Palsy and acquired brain injury. Families travel from [...]

  • How brain injury case managers support their clients

    By Laura Collins and Lucy Jane O'Connor, Unite Professionals Case Management Brain injury rehabilitation is a journey, not a race. Supporting an individual to be ready for rehabilitation is a process which needs to be managed with great care, empathy and consideration from the onset. The brain is involved in almost everything we do. An [...]

  • ABILITY Neurotech gets approval to trial brain-computer interface in ALS patients

    ABILITY Neurotech has announced it has received Investigational Medical Device Dossier (IMDD) approval from the Medical Research Ethics Committee (MREC) NedMec in the Netherlands to initiate the first chronic implantation study of the company’s fully implantable wireless optical-link ECoG BCI in patients with amyotrophic lateral sclerosis (ALS). ABILITY is a clinical-stage brain-computer interface (BCI) company [...]